PlainPharmaWatch

CMS Open Payments · Program Year 2024

AltaThera Pharmaceuticals LLC

AltaThera Pharmaceuticals LLC reported $230,253.55 in payments to 791 physicians and teaching hospitals across 791 transactions.

See the rankings → How this is sourced
$230.3K
Total payments
791
Transactions
791
Recipients
+$69.0K
General Payments vs PY2023

AltaThera Pharmaceuticals LLC reported $230,253.55 in payments to 791 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #964 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $291.09 per recipient across 2 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

AltaThera Pharmaceuticals LLC pairs below-median payment volume with an unusually diversified payment pattern across a wide recipient base.

#964
of 1,925 companies
0.0%
of all US industry payments
0.1%
paid to its single top recipient
2
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

AltaThera Pharmaceuticals LLC's CMS-reported General Payments increased by $69.0K (+42.8%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: ALTATHERA PHARMACEUTICALS LLCPY2023: ALTATHERA PHARMACEUTICALS LLCPY2024: AltaThera Pharmaceuticals LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$161.2KPY2024$230.3K
PY2023
$161,215.79
PY2024
$230,253.55

How AltaThera Pharmaceuticals LLC ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

AltaThera Pharmaceuticals LLC's total vs. every reporting company

CMS Open Payments, Program Year 2024

$230,254 Top 50% higher than 50% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). This entry sits in this band. $242,294–$752,621: 270 reporting companies (14%). Above this entry. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for AltaThera Pharmaceuticals LLC

Averaging $291.09 per transaction and $291.09 per recipient, AltaThera Pharmaceuticals LLC's Program Year 2024 total comes to $230,253.55 across 791 transactions and 791 physicians and teaching hospitals. In the CMS Open Payments database that is good for rank #964 of 1,925 companies, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $202.6K, accounting for 88.0% of the company's reported total and 137 transactions.

General Payment Breakdown by Type

"Consulting Fee" leads AltaThera Pharmaceuticals LLC's 2-category general-payment breakdown at $202.6K, 88.0% of the reported total.

How AltaThera Pharmaceuticals LLC divides its payments

Top payment categories by total reported dollar volume

1. Consulting Fee$202.6K2. Food and Beverage$27.6K
Payment Type Amount Transactions
Consulting Fee $202.6K 137
Food and Beverage $27.6K 654

Recipient Concentration in General Payments

The five largest recipient relationships account for $61,176.46 (26.6%) of $230,253.55 in this company's General Payments records across 570 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for AltaThera Pharmaceuticals LLC

The five named recipients with the highest reported General Payments from this company

Alejandro Borquez$26.6KJonathan Hsu$15.6KThomas Jared Bunch$7.0KThomas Francis Deering$6.0KKevin Kwaku$6.0K
  1. 1

    Alejandro Borquez

    $26,592.01 across 14 reported transactions

  2. 2

    Jonathan Hsu

    $15,594.21 across 7 reported transactions

  3. 3

    Thomas Jared Bunch

    $7,000.00 across 1 reported transactions

  4. 4

    Thomas Francis Deering

    $6,007.59 across 4 reported transactions

  5. 5

    Kevin Kwaku

    $5,982.65 across 4 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $291.09. Average per recipient: $291.09.

Total Amount

$230,253.55

Avg per Transaction

$291.09

Avg per Recipient

$291.09

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

AltaThera Pharmaceuticals LLC Share

0.0%

#964 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to AltaThera Pharmaceuticals LLC

Neuromechanical Innovations, LLC

$229.6K 12 recipients

Darby Dental Supply, LLC

$229.5K 119 recipients

Acclarent, Inc

$232.0K 1,119 recipients

VentureMed Group, Inc.

$227.4K 54 recipients

Carl Zeiss Meditec Cataract Technology Inc.

$227.1K 53 recipients

Captiva Spine Inc

$227.0K 74 recipients

Frequently Asked Questions

How much did AltaThera Pharmaceuticals LLC pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $230,253.55 from AltaThera Pharmaceuticals LLC to physicians and hospitals across 791 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from AltaThera Pharmaceuticals LLC? ▾
AltaThera Pharmaceuticals LLC made payments to 791 physicians and teaching hospitals in 2024. The average payment per recipient was $291.09.
What types of payments did AltaThera Pharmaceuticals LLC make? ▾
2 categories of general payment make up AltaThera Pharmaceuticals LLC's reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Consulting Fee" at $202.6K, representing 88.0% of the company's reported total.
How does AltaThera Pharmaceuticals LLC rank among pharmaceutical companies? ▾
AltaThera Pharmaceuticals LLC ranks #964 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from AltaThera Pharmaceuticals LLC? ▾
In 2024, AltaThera Pharmaceuticals LLC averaged $291.09 per transaction across 791 transactions to 791 recipients.
Where does the payment data for AltaThera Pharmaceuticals LLC come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download AltaThera Pharmaceuticals LLC's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.